Showing results (251-260 of 261) with videos related to

Sort By:
Pageof 27
British Journal of Cancer|July 3, 2008
Variation in dermcidin expression in a range of primary human tumours and in hypoxic/oxidatively stressed human cell linesG D Stewart, R J E Skipworth, C J Pennington, et al.
British Journal of Cancer|January 27, 2011
ERK5 signalling in prostate cancer promotes an invasive phenotypeA K Ramsay, S R C McCracken, M Soofi, et al.
The Journal of Biological Chemistry|August 22, 2001
Interferon-kappa, a novel type I interferon expressed in human keratinocytesD W LaFleur, B Nardelli, T Tsareva, et al.
British Journal of Cancer|June 9, 2012
mRNA profiling of the cancer degradome in oesophago-gastric adenocarcinomaJ P Baren, G D Stewart, A Stokes, et al.
British Journal of Cancer|June 11, 2008
CD133/prominin-1 is a potential therapeutic target for antibody-drug conjugates in hepatocellular and gastric cancersL M Smith, A Nesterova, M C Ryan, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|January 26, 2017
First-in-human phase 1 study of margetuximab (MGAH22), an Fc-modified chimeric monoclonal antibody, in patients with HER2-positive advanced solid tumorsY J Bang, G Giaccone, S A Im, et al.
Journal of Dental Research|January 12, 2023
Acute Postoperative Pain Due to Dental Extraction in the Adult Population: A Systematic Review and Network Meta-analysisA Miroshnychenko, S Ibrahim, M Azab, et al.
The Journal of Pharmacology and Experimental Therapeutics|June 16, 2001
In vivo inhibition of Fas ligand-mediated killing by TR6, a Fas ligand decoy receptorK Connolly, Y H Cho, R Duan, et al.
Science (New York, N.Y.)|July 10, 1999
BLyS: member of the tumor necrosis factor family and B lymphocyte stimulatorP A Moore, O Belvedere, A Orr, et al.
Pageof 27